The Experts below are selected from a list of 199059 Experts worldwide ranked by ideXlab platform

Yaotseng Chen - One of the best experts on this subject based on the ideXlab platform.

  • cancer testis Antigen Expression in testicular germ cell tumors and in intratubular germ cell neoplasia
    Modern Pathology, 2015
    Co-Authors: Yaotseng Chen
    Abstract:

    Cancer testis Antigen Expression in testicular germ cell tumors and in intratubular germ cell neoplasia

  • immunohistochemical analysis of ny eso 1 Antigen Expression in normal and malignant human tissues
    International Journal of Cancer, 2001
    Co-Authors: Achim A Jungbluth, Yaotseng Chen, Elisabeth Stockert, Klaus J Busam, Denise Kolb, Kristin Iversen, Keren Coplan, Barbara Williamson, Nasser K Altorki, Lloyd J Old
    Abstract:

    NY-ESO-1, a member of the CT (cancer/testis) family of Antigens, is expressed in normal testis and in a range of human tumor types. Knowledge of NY-ESO-1 Expression has depended on RT-PCR detection of mRNA and there is a need for detecting NY-ESO-1 at the protein level. In the present study, a method for the immunochemical detection of NY-ESO-1 in paraffin-embedded tissues has been developed and used to define the Expression pattern of NY-ESO-1 in normal tissues and in a panel of human tumors. No normal tissue other than testis showed NY-ESO-1 reactivity, and Expression in testis was restricted to germ cells particularly spermatogonia. In human tumors, the frequency of NY-ESO-1 Antigen Expression corresponds with past analysis of NY-ESO-1 mRNA Expression e.g., 20-30% of lung cancers, bladder cancers and melanoma, and no Expression in colon and renal cancer. Co-typing of NY-ESO-1 Antigen and mRNA Expression in a large panel of lung cancers showed a good correlation. There is great variability in NY-ESO-1 Expression in individual tumors, ranging from an infrequent homogeneous pattern of staining to highly heterogeneous Antigen Expression.

Anthony J Schaeffer - One of the best experts on this subject based on the ideXlab platform.

  • variation of blood group Antigen Expression on vaginal cells and mucus in secretor and nonsecretor women
    The Journal of Urology, 1994
    Co-Authors: Anthony J Schaeffer, Elena L Navas, Mario F Venegas, Byron E Anderson, Claire Kanerva, Joan S Chmiel, James L Duncan
    Abstract:

    AbstractThe Expression of blood group Antigens on the surface of urothelial cells and in mucus is controlled partly by the blood type and secretor status of the individual. To our knowledge, the possibility that the levels of these Antigens vary with time has not been previously assessed. We determine if the pattern and/or intensity of blood group Antigen Expression on vaginal epithelial cells and mucus changed with time. Cell and mucus specimens were collected weekly for 3 months from 10 women: 5 (2 secretors and 3 nonsecretors) with and 5 (3 secretors and 2 nonsecretors) without a history of urinary tract infections. In addition, samples were collected on 5 consecutive days from 5 of these individuals. The cell and mucus samples were assayed for ABH and Lewis blood group Antigens using monoclonal antibodies in cell concentration immunofluorescence and enzyme-linked fluorogenic assays, respectively. Although the pattern of Antigen Expression in the vaginal cell and mucus samples was consistent with the b...

  • blood group Antigen Expression on vaginal cells and mucus in women with and without a history of urinary tract infections
    The Journal of Urology, 1994
    Co-Authors: Elena L Navas, Mario F Venegas, Byron E Anderson, Claire Kanerva, Joan S Chmiel, James L Duncan, Anthony J Schaeffer
    Abstract:

    AbstractAdherence of bacteria to carbohydrate receptors on the surface of vaginal epithelial cells is a critical event that precedes bacterial colonization of the vaginal mucosa and subsequent urinary tract infection. Blood group Antigens, carbohydrate structures bound to lipids or proteins, constitute an important component of the uroepithelial cell membrane and may affect susceptibility to urinary tract infections. To determine if the ABH and Lewis Antigen Expression in women with a history of urinary tract infections differed from that of women without such a history, vaginal specimens from 87 women (42 patients and 45 controls) were analyzed for the detection of these Antigenic determinants using monoclonal antibodies in quantitative immunoassays. The profile of ABH Antigen Expression was generally consistent with the ABO phenotype of the individual and appeared to be influenced by the secretor status. Secretors expressed higher levels of A, B and H determinants than nonsecretors. In addition, Lewis a...

  • blood group Antigen Expression on vaginal and buccal epithelial cells and mucus in secretor and nonsecretor women
    The Journal of Urology, 1993
    Co-Authors: Elena L Navas, Mario F Venegas, Byron E Anderson, Joan S Chmiel, James L Duncan, Anthony J Schaeffer
    Abstract:

    AbstractBlood group Antigens on epithelial cells may influence bacterial adherence to mucosal surfaces. In the urinary tract the presence of these genetically determined carbohydrate structures may affect bacterial colonization of the vaginal mucosa and subsequent urinary tract infection. In previous studies the detection of ABH and Lewis Antigen Expression and distribution in tissues have made use of semiquantitative immunohistochemical staining techniques. To determine the pattern and intensity of blood group Antigens on epithelial cells and in the mucus overlying them, we developed quantitative immunoassays that use monoclonal antibodies to detect changes in the Expression and intensity of ABH and Lewis Antigens on cells and in mucus. Vaginal and buccal cell specimens from 23 healthy women (15 secretors and 8 nonsecretors) with no history of urinary tract infections and known blood group types were analyzed for the Expression of these Antigenic determinants. The profile of ABH Antigen Expression was ge...

Holger Moch - One of the best experts on this subject based on the ideXlab platform.

  • cancer testis Antigen Expression in testicular germ cell tumorigenesis
    Modern Pathology, 2014
    Co-Authors: Peter K Bode, Andrea Thielken, Simone Brandt, Andre Barghorn, Bernd Lohe, Alexander Knuth, Holger Moch
    Abstract:

    Cancer testis Antigens are encoded by germ line-associated genes that are present in normal germ cells of testis and ovary but not in differentiated tissues. Their Expression in various human cancer types has been interpreted as ‘re-Expression’ or as intratumoral progenitor cell signature. Cancer testis Antigen Expression patterns have not yet been studied in germ cell tumorigenesis with specific emphasis on intratubular germ cell neoplasia unclassified as a precursor lesion for testicular germ cell tumors. Immunohistochemistry was used to study MAGEA3, MAGEA4, MAGEC1, GAGE1 and CTAG1B Expression in 325 primary testicular germ cell tumors, including 94 mixed germ cell tumors. Seminomatous and non-seminomatous components were separately arranged and evaluated on tissue microarrays. Spermatogonia in the normal testis were positive, whereas intratubular germ cell neoplasia unclassified was negative for all five CT Antigens. Cancer testis Antigen Expression was only found in 3% (CTAG1B), 10% (GAGE1, MAGEA4), 33% (MAGEA3) and 40% (MAGEC1) of classic seminoma but not in non-seminomatous testicular germ cell tumors. In contrast, all spermatocytic seminomas were positive for cancer testis Antigens. These data are consistent with a different cell origin in spermatocytic seminoma compared with classic seminoma and support a progression model with loss of cancer testis Antigens in early tumorigenesis of testicular germ cell tumors and later re-Expression in a subset of seminomas.

Daniel A Arber - One of the best experts on this subject based on the ideXlab platform.

Davide Lauro - One of the best experts on this subject based on the ideXlab platform.

  • hla class ii Antigen Expression in colorectal carcinoma tumors as a favorable prognostic marker
    Neoplasia, 2014
    Co-Authors: Giuseppe Sconocchia, Giulio C Spagnoli, Serenella Eppenbergercastori, Inti Zlobec, Evanthia Karamitopoulou, Roberto Arriga, Andrea Coppola, Sara Caratelli, Davide Lauro
    Abstract:

    The goal of this study was to determine the frequency of HLA class II Antigen Expression in colorectal carcinoma (CRC) tumors, its association with the clinical course of the disease, and the underlying mechanism(s). Two tissue microarrays constructed with 220 and 778 CRC tumors were stained with HLA-DR, DQ, and DP Antigen-specific monoclonal antibody LGII-612.14, using the immunoperoxidase staining technique. The immunohistochemical staining results were correlated with the clinical course of the disease. The functional role of HLA class II Antigens expressed on CRC cells was analyzed by investigating their in vitro interactions with immune cells. HLA class II Antigens were expressed in about 25% of the 220 and 21% of the 778 tumors analyzed with an overall frequency of 23%. HLA class II Antigens were detected in 19% of colorectal adenomas. Importantly, the percentage of stained cells and the staining intensity were significantly lower than those detected in CRC tumors. However, HLA class II Antigen staining was weakly detected only in 5.4% of 37 normal mucosa tissues. HLA class II Antigen Expression was associated with a favorable clinical course of the disease. In vitro stimulation with interferon gamma (IFNγ) induced HLA class II Antigen Expression on two of the four CRC cell lines tested. HLA class II Antigen Expression on CRC cells triggered interleukin-1β (IL-1β) production by resting monocytes. HLA class II Antigen Expression in CRC tumors is a favorable prognostic marker. This association may reflect stimulation of IL-1β production by monocytes.